AI Liver SolutionAI for Increasing Reporting of Fatty Liver to Promote Early Detection
Nanox.AI’s unique and pioneering algorithm highlights liver density measurements using abdominal and chest CTs. Low liver density is suggestive of fatty liver disease.
Discover the Need for
Advanced Liver Care
Proven Value
In a study published in AJR, the Nanox.AI liver solution demonstrated enhanced diagnostic accuracy and automation efficiency
FLD and Cardiovascular Risk
There is a strong association between NAFLD and atherosclerotic heart disease, heart failure, and arrhythmias, particularly atrial fibrillation
Want to Learn More?
AI Solutions for Better Outcomes
Improving Clinical Outcome
The AI-driven analysis enhances clinical outcomes by automatically measuring liver attenuation on contrast and non-contrast chest and abdominal CT scans.
Generating Value
Nanox.AI measures liver attenuation (HU), highlights results that fall outside the reference range, and visualizes the measurement location.
Seamless Integration
Seamless integration with existing Picture Archiving and Communication Systems (PACS) enables timely and appropriate preventive care.
Adding Clinical Value to Radiology Reports
The AI Liver solution helps bridge the divide between radiology and gastroenterology, two medical specialties that often use different terms and descriptions to assess imaging data by adding clinical value as numerical scoring to the radiology report
Exploring Insights and Innovations
Explore leading articles in the field of medical imaging, featuring cutting-edge research, breakthrough technologies, and in-depth analyses of the future of medicine. Read more and stay updated with the latest knowledge and development.
Article AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
This new AASLD Guidance document reflects many advances in the field pertinent to any practitioner caring for patients with NAFLD and emphasizes advances in noninvasive risk stratification and therapeutics.
15 Minutes reading
Article Detection of Moderate Hepatic Steatosis on Portal Venous Phase Contrast-Enhanced CT: Evaluation Using an Automated Artificial Intelligence Tool
Precontrast CT is an established means of evaluating for hepatic steatosis; postcontrast CT has historically been limited for this purpose.
10 Minutes reading
Article Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey
To evaluate the association between non-alcoholic fatty liver disease (NAFLD), heart failure (HF), and all-cause mortality. Both NAFLD and HF are increasing in prevalence due to shared risk factors.
Client portal